Search results
Showing 3661 to 3675 of 8235 results
A timeline showing where in the NICE evaluation process companies will be charged.
A step-by-step summary about how we develop our technology appraisal guidance.
Health Technology Assessment Innovation Laboratory (HTA Lab)
NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.
Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.
This guidance evaluates digital technologies, diagnostics and medical devices (including artificial intelligence).
Biographies for all current members of the diagnostics advisory committee.
Membership details, terms of reference, future meeting dates and past meeting minutes for our 4 technology appraisal committees.
How to register with us as a diagnostic technologies stakeholder.
How to register with us as a medical technologies stakeholder.
People and communities - putting you at the heart of our work
NICE is committed to involving people who use services, carers and the public in the development of our guidance and other products.
Our recommendations on the use of highly specialised technologies are made by an independent advisory committee
Advises NICE on the formulation of its guidance on the safety and efficacy of interventional procedures.
Find out more about the NICE technology appraisal advisory committee B members and their registered interests
Biographies and registered interests for members of the Technology Appraisal Committee A
A new model for evaluating and purchasing antimicrobials in the UK
Overview of NICE and NHS England’s pioneering subscription-style purchasing model for antimicrobials: its pilot with ceftazidime-avibactam and cefiderocol in 2022, expansion in 2024, supporting health technology assessments, downloadable guidance and procurement tools.